Skip to main content

Nasdaq ETFs

GBIL Shares Cross Below 200 DMA

2 years 5 months ago
In trading on Wednesday, shares of the GBIL ETF (Symbol: GBIL) crossed below their 200 day moving average of $99.94, changing hands as low as $99.66 per share. GBIL shares are currently trading down about 0.4% on the day. The chart below shows the one year performance of GBIL
BNK Invest

Analysts Anticipate SDVY Will Reach $36

2 years 5 months ago
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself.
BNK Invest

Analysts Predict 10% Upside For The Holdings of VYM

2 years 5 months ago
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself.
BNK Invest

Analysts Anticipate ONEY To Hit $113

2 years 5 months ago
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself.
BNK Invest

Sum Up The Pieces: PRF Could Be Worth $41

2 years 5 months ago
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself.
BNK Invest

LLY Crosses Above Average Analyst Target

2 years 5 months ago
In recent trading, shares of Lilly (Eli) & Co (Symbol: LLY) have crossed above the average analyst 12-month target price of $774.48, changing hands for $781.10/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade o
BNK Invest

ATI Crosses Above Average Analyst Target

2 years 5 months ago
In recent trading, shares of ATI Inc (Symbol: ATI) have crossed above the average analyst 12-month target price of $56.88, changing hands for $59.70/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, o
BNK Invest

Analysts Anticipate FTC To Hit $128

2 years 5 months ago
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself.
BNK Invest

Innovative Industrial Properties Reaches Analyst Target Price

2 years 5 months ago
In recent trading, shares of Innovative Industrial Properties Inc (Symbol: IIPR) have crossed above the average analyst 12-month target price of $100.75, changing hands for $103.40/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to r
BNK Invest

Leidos Holdings Reaches Analyst Target Price

2 years 5 months ago
In recent trading, shares of Leidos Holdings Inc (Symbol: LDOS) have crossed above the average analyst 12-month target price of $135.33, changing hands for $140.22/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade o
BNK Invest

Tenet Healthcare Reaches Analyst Target Price

2 years 5 months ago
In recent trading, shares of Tenet Healthcare Corp. (Symbol: THC) have crossed above the average analyst 12-month target price of $109.70, changing hands for $112.29/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade
BNK Invest

Timken Reaches Analyst Target Price

2 years 5 months ago
In recent trading, shares of Timken Co. (Symbol: TKR) have crossed above the average analyst 12-month target price of $87.40, changing hands for $89.22/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation
BNK Invest

Heartland Financial USA Reaches Analyst Target Price

2 years 5 months ago
In recent trading, shares of Heartland Financial USA, Inc. (Symbol: HTLF) have crossed above the average analyst 12-month target price of $41.20, changing hands for $42.11/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: do
BNK Invest

How The Parts Add Up: TDIV Headed For $76

2 years 5 months ago
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself.
BNK Invest

How The Parts Add Up: SLYG Targets $95

2 years 5 months ago
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself.
BNK Invest

Look Under The Hood: PWV Has 10% Upside

2 years 5 months ago
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself.
BNK Invest

Innovation at Scale: Ginkgo Bioworks’ Approach to Revolutionizing Industries

2 years 5 months ago
We live in the age of the elevator pitch, catchy soundbites, and companies promising to revolutionize every industry under the sun. No other field attracts more visionaries than healthcare. After all, who doesn’t like the idea of living a longer and healthier life? All these futurists must contend with the reality that biology is the [...] Read more at ETFTrends.com.
ETF Trends

ETF Prime: Mercer on AI Investing & Developments + CLOs

2 years 5 months ago
On this week’s episode of ETF Prime, Host Nate Geraci was joined by VettaFi Senior Research Analyst Zeno Mercer to discuss the artificial intelligence field and AI-related ETFs. Afterward, Geraci welcomed John Kim, Panagram CEO & CIO, to discuss his firm’s CLOs ETFs. Quarterly Outlooks Geraci asked Mercer to weigh in on the AI-related discussions [...] Read more at ETFTrends.com.
ETF Trends
Checked
18 minutes 15 seconds ago
This feed is responsible for generating the rss feed related to the topic ETFs
Subscribe to Nasdaq ETFs feed